RxDoctor Payments Data

Kamar Godder

Pediatric Hematology-Oncology · Miami, FLNPI 1902900335

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Amgen at 54.3% of the total. That places this record below the midpoint for pediatric hematology-oncology clinicians in FL, where the typical reported total is $471.

$471in general payments, 2019–2025

Across 10 payments — averaging $47.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$255
  • Novartis$185
  • Octapharma USA, Inc.$31
$409,618in research payments, 2019–2025

Across 160 payments — averaging $2560.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$261K
  • Astellas Pharma Global Development$97K
  • Astellas US Technologies$32K
  • Bayer$19K
  • National Marrow Donor Program$428

What the payments were for

  • Food & beverage$471100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen4$255
Novartis5$185
Octapharma USA, Inc.1$31

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$471 in reported general payments places this provider in the 50th percentile of 132 pediatric hematology-oncology providers in Florida.

See all pediatric hematology-oncology providers in Florida

Other pediatric hematology-oncology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →